Skip to main content
Radcliffe Medical Education
Medical education learning resources for healthcare professionals
Radcliffe Medical Education banner
Radcliffe Medical Education banner
  • Home
  •  The Rise of CVRM Medicine: Managing Common Co-morbidities as One — A Multi-specialty Virtual Event

The Rise of CVRM Medicine: Managing Common Co-morbidities as One — A Multi-specialty Virtual Event

Topic:
  • CV Renal Metabolic
  • Prevention

Available Credit:

  • 3.00 EBAC

Course Published On:

Course Expiry Date:

The Rise of CVRM Medicine: Managing Common Co-morbidities as One — A Multi-specialty Virtual Event
No ratings

Overview

This educational course led by Dr Neha Pagidipati (Duke Clinical Research Institute, North Carolina, US) and Prof Carel Le Roux (University College Dublin, Dublin, IE) provides a thorough and flexible learning experience centred on the management of Cardiovascular-Renal-Metabolic (CVRM) disease, highlighting the complex interplay between type 2 diabetes (T2DM), chronic kidney disease (CKD), and atherosclerotic cardiovascular disease (ASCVD). Designed to be accessed at your convenience, the programme allows healthcare professionals to engage deeply with the content and apply the insights directly to clinical practice.

 

The course was developed to equip healthcare professionals with the knowledge and skills to recognise at-risk patients, initiate timely and appropriate interventions and foster effective multidisciplinary collaboration, ultimately enhancing care delivery and patient outcomes across the CVRM pathway.

Support Statement

This programme is supported by an unrestricted educational grant from NOVO NORDISK A/S.

 

This content is intended for an international audience of non-US and non-UK HCPs.

Disclosure

In compliance with EBAC guidelines, all speakers/chairpersons participating in this programme have disclosed or indicated potential conflicts of interest which might cause a bias in the presentations.

 

The Organising Committee/Course Director is responsible for ensuring that all potential conflicts of interest relevant to the event are declared to the audience prior to the CME activities.

Terms & Conditions

Radcliffe Education requires contributors to our CME programmes to disclose any relevant financial relationships that have occurred within the past 12 months that could create a conflict of interest. These will be identified in the faculty section if applicable.

 

The session, ‘The Rise of CVRM Medicine: Managing Common Co-morbidities as One — A Multi-specialty Virtual Event’ is accredited by the European Board for Accreditation of Continuing Education for Health Professionals (EBAC) for 3 hours of external CME credits.

 

Each participant should claim only those hours of credit that have actually been spent in the educational activity. EBAC works according to the quality standards of the European Accreditation Council for Continuing Medical Education (EACCME), which is an institution of the European Union of Medical Specialists (UEMS).

 

Through an agreement between the European Board for Accreditation in Cardiology and the American Medical Association, physicians may convert EBAC External CME credits to AMA PRA Category 1 Credits™. Information on the process to convert EBAC credit to AMA credit can be found on the AMA website.

Instruction to Participants

There is no fee for taking part in this online learning activity.

 

Activities are designed to be completed within 180 minutes and must be completed by the registered user. Physicians should only claim credits for time spent on the activity. To successfully earn credit, participants must complete the activity in full in the indicated time frame.

 

To complete the course and claim certification participants must:

 

  • Read the course outline information supplied and complete pre-test questions if supplied prior to starting the activity. Users must read and study the activity in its entirety before completing the post-test questions.

 

  • Your results will be automatically saved and if a pass score is achieved (where applicable), you may be eligible to claim credit for the activity and receive a certificate of completion.

Target Audience

  • Primary Care Physicians and Specialists
  • Endocrinologists
  • Diabetologists
  • Cardiologists
  • Nephrologists

Learning Objectives

Upon completion of this activity, participants will be able to:

  • Describe the link between T2DM, CKD and ASCVD
  • State the importance of early and effective intervention in managing CVRM disease progression
  • List the guideline directed therapeutic targets in CVRM disease
  • Select appropriate patients for holistic CVRM management
  • Recall trial data for novel therapeutic agents that carry benefit for CVRM outcomes
  • Develop a holistic management strategy for CVRM disease with an evidence-based impact on clinical outcomes
3.00 EBAC